Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

PHASE2CompletedINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

PH-797804

6 mg oral tablet once daily for 12 weeks

DRUG

Placebo

Placebo oral tablet once daily for 12 weeks

Trial Locations (74)

1125

Pfizer Investigational Site, Budapest

1407

Pfizer Investigational Site, Sofia

1426

Pfizer Investigational Site, Buenos Aires

1431

Pfizer Investigational Site, Sofia

2000

Pfizer Investigational Site, Rosario

3110

Pfizer Investigational Site, Tauranga

4001

Pfizer Investigational Site, Durban

4126

Pfizer Investigational Site, eManzimtoti

5041

Pfizer Investigational Site, Daw Park

5400

Pfizer Investigational Site, Sevlievo

5703

Pfizer Investigational Site, Gyula

6003

Pfizer Investigational Site, Stara Zagora

6009

Pfizer Investigational Site, Nedlands

6021

Pfizer Investigational Site, Newtown

6722

Pfizer Investigational Site, Szeged

7002

Pfizer Investigational Site, Rousse

7505

Pfizer Investigational Site, Tygerberg Campus

7530

Pfizer Investigational Site, Bellville

9301

Pfizer Investigational Site, Bloemfontein

9700

Pfizer Investigational Site, Szombathely

22185

Pfizer Investigational Site, Lund

29303

Pfizer Investigational Site, Spartanburg

30071

Pfizer Investigational Site, Norcross

30094

Pfizer Investigational Site, Conyers

30096

Pfizer Investigational Site, Duluth

32504

Pfizer Investigational Site, Pensacola

33603

Pfizer Investigational Site, Tampa

33613

Pfizer Investigational Site, Tampa

33756

Pfizer Investigational Site, Clearwater

34655

Pfizer Investigational Site, Trinity

36608

Pfizer Investigational Site, Mobile

39001

Pfizer Investigational Site, Tábor

45231

Pfizer Investigational Site, Cincinnati

45245

Pfizer Investigational Site, Cincinnati

48152

Pfizer Investigational Site, Livonia

55407

Pfizer Investigational Site, Minneapolis

55432

Pfizer Investigational Site, Fridley

55905

Pfizer Investigational Site, Rochester

63141

Pfizer Investigational Site, St Louis

75069

Pfizer Investigational Site, McKinney

77030

Pfizer Investigational Site, Houston

85306

Pfizer Investigational Site, Glendale

92120

Pfizer Investigational Site, San Diego

2260494

Pfizer Investigational Site, Quillota

2352499

Pfizer Investigational Site, Valparaíso

02865

Pfizer Investigational Site, Lincoln

C1440BRR

Pfizer Investigational Site, Capital Federal

T1Y 6J4

Pfizer Investigational Site, Calgary

L2G 1J4

Pfizer Investigational Site, Niagara Falls

K1Y 4G2

Pfizer Investigational Site, Ottawa

M6H 3M2

Pfizer Investigational Site, Toronto

G1V 4G5

Pfizer Investigational Site, Québec

G8T 7A1

Pfizer Investigational Site, Trois-Rivières

284 01

Pfizer Investigational Site, Kutná Hora

460 01

Pfizer Investigational Site, Liberec

530 09

Pfizer Investigational Site, Pardubice

108 00

Pfizer Investigational Site, Praha 10- Malesice

380 052

Pfizer Investigational Site, Ahmedabad

440 012

Pfizer Investigational Site, Nagpur

641 004

Pfizer Investigational Site, Coimbatore

04-141

Pfizer Investigational Site, Warsaw

47-120

Pfizer Investigational Site, Zawadzkie

21-010

Pfizer Investigational Site, Łęczna

972 01

Pfizer Investigational Site, Bojnice

826 06

Pfizer Investigational Site, Bratislava

040 01

Pfizer Investigational Site, Košice

033 01

Pfizer Investigational Site, Liptovský Hrádok

017 26

Pfizer Investigational Site, Považská Bystrica

052 01

Pfizer Investigational Site, Spišská Nová Ves

400 14

Pfizer Investigational Site, Gothenburg

413 45

Pfizer Investigational Site, Gothenburg

171 76

Pfizer Investigational Site, Stockholm

HU16 5JQ

Pfizer Investigational Site, Cottingham

G12 OYN

Pfizer Investigational Site, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01321463 - Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination | Biotech Hunter | Biotech Hunter